Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
Development of an improved vaccine against tuberculosis (TB) is hindered by the lack of a surrogate of protection. Efficacy of new TB vaccines in humans can only be evaluated by expensive and time consuming efficacy trials within TB endemic areas. It is critical that vaccines with the greatest poten...
Main Authors: | Marsay, L, Matsumiya, M, Tanner, R, Poyntz, H, Griffiths, K, Stylianou, E, Marsh, P, Williams, A, Sharpe, S, Fletcher, H, McShane, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
by: Marsay, L, et al.
Published: (2013) -
Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
by: Tanner, R, et al.
Published: (2021) -
Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
by: Poyntz, H, et al.
Published: (2014) -
Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
by: Poyntz, H, et al.
Published: (2014) -
Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
by: Christina Jensen, et al.
Published: (2017-06-01)